People on the Move: Biotechnology/Biopharma Companies

, , , , ,

 

A2A Pharmaceuticals Inc. named Dr. Sotirios G. Stergiopoulos as president and CEO. He has held the position as founder and chairman since 2016. Dr. Stergiopoulos will maintain a seat on the board.

Dr. Sotirios G. Stergiopoulos

Jotin Marango, M.D., Ph.D., has been appointed senior VP, chief business officer of Aptose Biosciences Inc. He brings to Aptose many years of industry experience, most recently as a senior research analyst at ROTH Capital Partners.

Don Vidic is now VP, head of commercial, at Agenus Inc. Prior to joining Agenus, he served as the chief pharmacy and growth officer at Walgreens Boots Alliance and as the general manager and VP at McKesson.

Dhana Chinnasamy, Ph.D., has been named VP, non-clinical and translational studies, at MaxCyte. Most recently, she led the immuno-oncology team at Precigen/Intrexon where she developed novel T cell products co-expressing chimeric antigen receptors (CARs) and cytokine genes targeting solid tumors.

Geoffrey S. Gilmartin, M.D., M.M.Sc., has been made chief medical officer and Andrey E. Belous, M.D., Ph.D., is senior medical director of Proteostasis Therapeutics Inc. Dr. Gilmartin served most recently as chief medical affairs officer of the company. Dr. Belous joins Proteostasis from Galapagos NV, where he most recently served as a medical director for the company’s Phase III program in idiopathic pulmonary fibrosis. Po-Shun Lee, M.D., after a four-year tenure as chief medical officer, transitioned out of his role and now serves as a consultant for Proteostasis.